DarioHealth Corp (NASDAQ: DRIO), a global digital therapeutics innovator, is collaborating with the American Diabetes Association (ADA) as a Living Red Sponsor of NYC - Step Out: Walk to Stop Diabetes, it was reported on Friday.
Dario will publish several studies performed using de-identified data from its broad data base of users, showcasing the clinical benefits of its Digital Therapeutics solution to help improve life with diabetes and achieve clinically-proven results at the ADA's 2019 Scientific Sessions conference in June 2019. The company offers a user mobile application to engage and educate its users on topics ranging from diabetes management to healthy nutrition and exercise, as well as a platform that allows healthcare professionals to access collected data and to provide recommendations to the individuals they are supporting. Data is collected from devices such as the Dario 3-in-1 blood glucose meter and other applications. Dario is an open system accepting connections with third party devices and external health coaches. It delivers aggregated analytics demonstrating the efficacy of its interventions.
Erez Raphael, DarioHealth's CEO, said, 'We are honoured and humbled to be recognised by the ADA as an organisation that can advance the ADA's cause of preventing and curing diabetes. Dario is striving to use its technology and expertise to engage its users in adopting healthier habits, with scientific-based results.'
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project